A Comprehensive Mendelian Randomization Study Investigating Multiple Exposures and Outcomes: Focusing on Nontoxic Goitre and Type 2 Diabetes Mellitus

Overview

Journal Clin Endocrinol (Oxf)

Specialty Endocrinology

Date 2024 Nov 11

PMID 39526404

Authors

Yizhi Wu

Zhenghong Yao

Yimin Wang

Yufei Lou

Tugen Yu

Rucheng Chen

Xinyang Shou

Weijia Gu

Affiliations

Soon will be listed here.

Abstract

Objective: Previous research suggests a correlation between nontoxic goitre and type 2 diabetes mellitus (T2DM). However, the causality was vulnerable to confounding variables. Therefore, there is an urgent need for a more rigorous research approach to examine the causal connection between nontoxic goitre and T2DM.

Design: Multiple exposures and outcomes two-sample Mendelian randomization (MR) study was carried out in two stages: nontoxic goitre traits (including nontoxic diffuse goitre, NDG; nontoxic multinodular goitre, NMG; and other/unspecified nontoxic goitre, OUNG) were investigated as exposure while T2DM was investigated as an outcome in the first step, whereas the second step was reversed. The GWAS summary data for nontoxic goitre traits and T2DM were collected from the Finngen database. The summary data for fasting glucose, fasting insulin, and HbA1c were obtained from the open GWAS database established by the MRC Integrated Epidemiology Unit (IEU). The inverse-variance weighted (IVW) approach was used to obtain MR estimates, and various sensitivity analysis was also performed.

Results: NDG had a potential protective causal relationship with T2DM (OR = 0.978; 95% CI: 0.957-0.998; p = 0.034) and fasting glucose (OR = 0.995; 95% CI: 0.990-0.999; p = 0.011), while NMG had a potential protective causal relationship with T2DM (OR = 0.941; 95% CI: 0.902-0.982; p = 0.008) and HbA1c (OR = 0.992; 95% CI: 0.986-0.998; p = 0.015). OUNG was found to decrease the odds of T2DM by 4.4% (OR = 0.966; 95% CI: 0.938-0.995, p = 0.023). T2DM had a potential causal relationship with NDG (OR = 1.239; 95% CI: 1.020-1.504; p = 0.031), and a potential protective effect against NMG (OR = 0.669; 95% CI: 0.566-0.792; p < 0.001) and OUNG (OR = 0.694; 95% CI: 0.545-0.883; p = 0.004). There was no evidence of a positive association between glycemic traits and nontoxic goitre traits (p > 0.05).

Conclusions: Our findings indicate a potential causal relationship between nontoxic goitre traits and T2DM. Specifically, our study addresses that NMG and T2DM may have a significant causal effect on each other in both directions.

References

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

Arora N, Scognamiglio T, Zhu B, Fahey 3rd T . Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg. 2008; 32(7):1237-46. DOI: 10.1007/s00268-008-9484-1. View

Bilic-Komarica E, Beciragic A, Junuzovic D . Effects of treatment with L-thyroxin on glucose regulation in patients with subclinical hypothyroidism. Med Arch. 2013; 66(6):364-8. DOI: 10.5455/medarh.2012.66.364-368. View

Burgess S, Bowden J, Fall T, Ingelsson E, Thompson S . Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiology. 2016; 28(1):30-42. PMC: 5133381. DOI: 10.1097/EDE.0000000000000559. View

Anil C, Kut A, Atesagaoglu B, Nar A, Tutuncu N, Gursoy A . Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study. Med Princ Pract. 2015; 25(3):233-6. PMC: 5588367. DOI: 10.1159/000442821. View

Leenhardt L, Grosclaude P . [Epidemiology of thyroid carcinoma over the world]. Ann Endocrinol (Paris). 2011; 72(2):136-48. DOI: 10.1016/j.ando.2011.03.025. View

Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-281. DOI: 10.1016/j.diabres.2018.02.023. View

Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S . Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006; 166(17):1871-7. DOI: 10.1001/archinte.166.17.1871. View

10.

Bowden J, Davey Smith G, Burgess S . Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015; 44(2):512-25. PMC: 4469799. DOI: 10.1093/ije/dyv080. View

11.

Yavorska O, Burgess S . MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017; 46(6):1734-1739. PMC: 5510723. DOI: 10.1093/ije/dyx034. View

12.

Tinajero M, Malik V . An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. Endocrinol Metab Clin North Am. 2021; 50(3):337-355. DOI: 10.1016/j.ecl.2021.05.013. View

13.

Anil C, Akkurt A, Ayturk S, Kut A, Gursoy A . Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism. 2013; 62(7):970-5. DOI: 10.1016/j.metabol.2013.01.009. View

14.

Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H . Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid. 2008; 18(4):461-4. DOI: 10.1089/thy.2007.0223. View

15.

Tang Y, Yan T, Wang G, Chen Y, Zhu Y, Jiang Z . Correlation between Insulin Resistance and Thyroid Nodule in Type 2 Diabetes Mellitus. Int J Endocrinol. 2017; 2017:1617458. PMC: 5660821. DOI: 10.1155/2017/1617458. View

16.

Santos M, Louzada R, Souza E, Fortunato R, Vasconcelos A, Souza K . Diabetes mellitus increases reactive oxygen species production in the thyroid of male rats. Endocrinology. 2013; 154(3):1361-72. DOI: 10.1210/en.2012-1930. View

17.

Heidari Z, Mashhadi M, Nosratzehi S . Insulin Resistance in Patients with Benign Thyroid Nodules. Arch Iran Med. 2015; 18(9):572-6. DOI: 0151809/AIM.005. View

18.

Hemani G, Bowden J, Davey Smith G . Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018; 27(R2):R195-R208. PMC: 6061876. DOI: 10.1093/hmg/ddy163. View

19.

Zhang H, Feng Q, Niu Y, Su Q, Wang X . Thyroid Nodules in Type 2 Diabetes Mellitus. Curr Med Sci. 2019; 39(4):576-581. DOI: 10.1007/s11596-019-2076-5. View

20.

Blanc E, Ponce C, Brodschi D, Nepote A, Barreto A, Schnitman M . Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome. Metab Syndr Relat Disord. 2015; 13(5):221-6. DOI: 10.1089/met.2014.0158. View